REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 220 filers reported holding REATA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $744,308 | +12.1% | 7,300 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $663,716 | +178.9% | 7,300 | -19.2% | 0.00% | – |
| Q4 2021 | $238,000 | -78.6% | 9,030 | -18.1% | 0.00% | -100.0% |
| Q3 2021 | $1,110,000 | -28.9% | 11,030 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,561,000 | +38.3% | 11,030 | -2.6% | 0.00% | 0.0% |
| Q1 2021 | $1,129,000 | -19.4% | 11,330 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,400,000 | +59.1% | 11,330 | +25.5% | 0.00% | 0.0% |
| Q3 2020 | $880,000 | -81.7% | 9,030 | -70.7% | 0.00% | -83.3% |
| Q2 2020 | $4,803,000 | +48.4% | 30,783 | +37.2% | 0.01% | +50.0% |
| Q1 2020 | $3,237,000 | -2.6% | 22,429 | +38.0% | 0.00% | +33.3% |
| Q4 2019 | $3,322,000 | – | 16,251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
| Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
| MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
| Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
| Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
| Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
| Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
| Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |